Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Internationally Recognized Certificates of Compliance
(IRCC)
last updated: 16 Aug 2016
ABSCH-IRCC-IN-207614-1
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
India/NBA/Appl/9/638
Application in Form-III for seeking approval for the invention " Use of two spoonful of plant powder to be taken orally with Luke-Warm water thrice a day and sulphur for giving sulphur bath and its ointment to be applied on skin over lesions playing major role in curing hyper-keratinization and scaling of psoriatic skin and prevention of penetration of ultra violet rays of sunlight by way of reflection and total relief from obscure chronic psoriatic skin disease with absolutely non-steroid therapy" for obtaining IP Rights in India
20 Nov 2014
Yes
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
Confidential information
Confidential information
Yes
1. The user shall notify the NBA on the grant of IPR within 30 days thereof.
2.If the user himself commercializes the process/product/innovation, he shall pay royalty at 3% of the highest ex-factory sale price of the product(s) sold or used for captive consumption.
3. The user needs to inform the NBA about any commercialization made on the IP Rights granted.
4. The user shall submit the half-yearly report to NBA as per the terms and conditions agreed upon.
Confidential information
Confidential information
1. In case the user assigns/licenses the innovation/ process/ product to a third party for commercialization:
The Applicant shall pay 5% of the fee received by him in any form (including the license fee / assignee fee). He shall also pay 5% of the annual royalty amount received by him, on an annual basis, from the assignee/ licensee throughout the term of the agreement.
OR
The assignee/licensee shall enter into a tripartite agreement with the Applicant and the NBA, to pay 5% of the lump sum payment made by him to the licensor and also royalty @ 5% of the highest ex-factory sale price of the product sold and also used for captive consumption to NBA.
| Unique identifier | Status | Date |
|---|---|---|
| ABSCH-IRCC-IN-207614-1 |
REVOKED
OLD VERSION
PUBLISHED
DELETED
|
Sujata Arora (sujata@nic.in)
16 Aug 2016 11:48 on 16 Aug 2016 11:48
|
